Novel Coronavirus Infection and Reproductive Function

Summary

This study aims to observe the impact of COVID-19 infection on the reproductive function and assisted pregnancy outcome of infertile couples undergoing assisted reproductive technology and to determine which factors are related to the clinical pregnancy rate. A multicenter, prospective, observational cohort study was adopted. Infertile couples who met the selection criteria were included in this study, the SAS anxiety self-rating scale was filled out, the basic situation was observed, and blood samples and related tissues were collected for testing. Relevant reproductive function, laboratory, clinical, and psychological indicators were collected, and the correlation between the above indicators and the outcome of the ART-related pregnancy were analyzed.

Conditions

• COVID-19 Infection

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

• Jinling Hospital, China

  lead OTHER

Principal Investigators

• Bing Yao, PHD · Department of Reproductive Medicine, Jinling Hospital

• Li Chen, PHD · Department of Reproductive Medicine, Jinling Hospital

• Xiaojie Huang, PHD · Department of Reproductive Medicine, Xuzhou Maternal and Child Health Care Hospital

• Jiayi Ding, PHD · Department of Reproductive Medicine, Nantong Maternal and Child Health Care Hospital

• Qin Sun, MD · Department of Reproductive Medicine, Jinling Hospital

• Meiling Li, PHD · Department of Reproductive Medicine, Jinling Hospital

• Cheng Zhou, MD · Department of Reproductive Medicine, Jinling Hospital

• Xi Chen, MD · Department of Reproductive Medicine, Jinling Hospital

• Yuming Feng, MD · Department of Reproductive Medicine, Jinling Hospital

• Juanjuan Xu, MD · Department of Reproductive Medicine, Jinling Hospital

• Haiyan Fu, MD · Department of Reproductive Medicine, Jinling Hospital

• Cencen Wang, MD · Department of Reproductive Medicine, Jinling Hospital

• Hong Zhang, MD · Department of Reproductive Medicine, Jinling Hospital

• Lu Zheng, MD · Department of Reproductive Medicine, Jinling Hospital

• Yuxiu Liu, PHD · Department of Critical Care Medicine, Jinling Hospital

• Xiaofang Tan, MD · Department of Reproductive Medicine, Nantong Maternal and Child Health Care Hospital

• Yunxia Zhu, MD · Department of Reproductive Medicine, Xuzhou Maternal and Child Health Care Hospital

• Jueraitetibaike Kadiliya, PHD · Department of Reproductive Medicine, Jinling Hospital

• Zhichan Zou, MD · Department of Reproductive Medicine, Jinling Hospital

Eligibility

Min Age

20 Years

Max Age

42 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-01-20

Primary Completion

2024-01-31

Completion

2024-01-31

Countries

• China

Study Locations